CERO THERAPEUTICS HOLDINGS, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($4.86M) | Nov 19, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($5.42M) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($5.42M) | Aug 22, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($5.11M) | May 15, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($4.23M) | Nov 19, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($2.45M) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.45M) | Aug 22, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.73M) | May 15, 2025 |
| Q3 | 2025 | Feb 13, 2024 | ($572.2K) | Nov 19, 2025 |
| Q1 | 2025 | Feb 13, 2024 | ($572.2K) | May 15, 2025 |
| Q2 | 2025 | Feb 13, 2024 | ($572.2K) | Aug 22, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.35M) | Nov 20, 2024 |
| Q3 | 2023 | Jun 30, 2023 | ($1.44M) | Nov 9, 2023 |
| Q2 | 2024 | Jun 30, 2023 | ($2.09M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.44M) | May 17, 2024 |
| Q2 | 2023 | Mar 31, 2023 | ($481.7K) | Aug 14, 2023 |
| Q3 | 2023 | Mar 31, 2023 | ($481.7K) | Nov 9, 2023 |
| Q3 | 2023 | Sep 30, 2022 | $84.5K | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($111.6K) | Aug 14, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($111.6K) | Nov 9, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($4.36M) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($4.72M) | Aug 22, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($4.95M) | May 15, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($4.40M) | Nov 19, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($5.15M) | Aug 22, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($3.65M) | May 15, 2025 |
| Q1 | 2025 | Feb 13, 2024 | ($897.1K) | May 15, 2025 |
| Q3 | 2025 | Feb 13, 2024 | ($897.1K) | Nov 19, 2025 |
| Q2 | 2025 | Feb 13, 2024 | ($897.1K) | Aug 22, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($1.54M) | Nov 20, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($2.41M) | Aug 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($2.44M) | May 17, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($836.7K) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($376.6K) | Aug 14, 2023 |